Mediators of the mitogenic action of human V1 vascular vasopressin receptors

被引:20
作者
Thibonnier, M [1 ]
Conarty, DM [1 ]
Plesnicher, CL [1 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Med, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2000年 / 279卷 / 05期
关键词
kinase activation; cell cycle; cell proliferation; arginine vasopressin;
D O I
10.1152/ajpheart.2000.279.5.H2529
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Arginine vasopressin (AVP) activation of V-1 vascular receptors (V(1)Rs) stimulates cell growth and proliferation in different tissues via cellular signaling pathways that remain to be identified. To explore the intracellular mediators of the mitogenic action of V1R, Chinese hamster ovary (CHO) cells were stably transfected with the human V1R cDNA clone we isolated previously. We assessed AVP effects on kinase activation (immunoblotting with phosphospecific antibodies), DNA synthesis (tritiated thymidine uptake), cell cycle progression (flow cytometry analysis after nuclear labeling with propidium iodide), and cell proliferation (conversion of the colorimetric reagent MTS) in the presence or absence of various pathway inhibitors. AVP stimulation of V(1)Rs leads to the phosphorylation of several kinases, an increase in DNA synthesis, a progression through the S and G(2)-M phases of the cell cycle, and an increase in cell proliferation. The mediators of the mitogenic action of V1R activation included calcium mobilization, coupling to a G(q) protein, and the simultaneous and parallel activation of several kinases, mainly calcium/calmodulin-dependent kinase II, phosphatidylinositol 3 kinase, protein kinase C, and p42/p44 mitogen-activated protein kinase.
引用
收藏
页码:H2529 / H2539
页数:11
相关论文
共 34 条
[1]  
Arai H, 1996, MOL PHARMACOL, V50, P522
[2]  
Bernstein KE, 1998, LAB INVEST, V78, P3
[3]   The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs) [J].
Clerk, A ;
Sugden, PH .
FEBS LETTERS, 1998, 426 (01) :93-96
[4]  
FORCE T, 1991, J BIOL CHEM, V266, P6650
[5]   Growth factors and mitogen activated protein kinases [J].
Force, T ;
Bonventre, JV .
HYPERTENSION, 1998, 31 (01) :152-161
[6]  
GRANOT Y, 1993, J BIOL CHEM, V268, P9564
[7]   The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades [J].
Gutkind, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :1839-1842
[8]   Apoptosis - Basic mechanisms and implications for cardiovascular disease [J].
Haunstetter, A ;
Izumo, S .
CIRCULATION RESEARCH, 1998, 82 (11) :1111-1129
[9]   Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway [J].
Hawes, BE ;
Luttrell, LM ;
vanBiesen, T ;
Lefkowitz, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12133-12136
[10]   DISTINCT PATHWAYS OF G(I)-MEDIATED AND G(Q)-MEDIATED MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION [J].
HAWES, BE ;
VANBIESEN, T ;
KOCH, WJ ;
LUTTRELL, LM ;
LEFKOWITZ, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) :17148-17153